乳腺组织中的雌激素：系统评价。
Estrogens in the breast tissue: a systematic review.
机构信息
Division of Public Health Sciences, Department of Surgery, Washington University in St. Louis School of Medicine, Campus Box 8100, 660 S. Euclid Avenue, St. Louis, MO 63110, USA.
出版信息
Cancer Causes Control. 2011 Apr;22(4):529-40. doi: 10.1007/s10552-011-9729-4. Epub 2011 Feb 1.
Abstract
The role of estrogens in breast carcinogenesis has been investigated at the level of whole body (plasma) and cell (molecular, receptors, etc.). Growing attention focused on the breast tissue being an intracrine organ, with potentially important local estrogen production in the breast. However, very little is known about the local breast tissue estrogen levels. Understanding the role of the tissue estrogens in breast carcinogenesis might open new avenues in breast cancer prevention. This systematic review summarizes published studies that measured local estrogen levels in the breast and offers suggestions for strategies to fill gaps in our existing scientific knowledge.
摘要
雌激素在乳腺癌发生中的作用已在全身（血浆）和细胞（分子、受体等）水平上进行了研究。人们越来越关注乳腺组织作为一种内分泌器官，在乳腺中可能具有重要的局部雌激素产生。然而，对于局部乳腺组织中的雌激素水平知之甚少。了解组织雌激素在乳腺癌发生中的作用可能为乳腺癌预防开辟新途径。本系统综述总结了已发表的测量乳腺局部雌激素水平的研究，并提出了一些建议，以填补我们现有科学知识中的空白。
相似文献
1
Estrogens in the breast tissue: a systematic review.乳腺组织中的雌激素：系统评价。
Cancer Causes Control. 2011 Apr;22(4):529-40. doi: 10.1007/s10552-011-9729-4. Epub 2011 Feb 1.
2
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
3
Alcohol consumption and cancer risk: understanding possible causal mechanisms for breast and colorectal cancers.饮酒与癌症风险：了解乳腺癌和结直肠癌可能的因果机制。
Evid Rep Technol Assess (Full Rep). 2010 Nov(197):1-151.
4
Oncoplastic breast-conserving surgery for women with primary breast cancer.原发性乳腺癌患者的肿瘤整形保乳手术。
Cochrane Database Syst Rev. 2021 Oct 29;10(10):CD013658. doi: 10.1002/14651858.CD013658.pub2.
5
Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.用于预防或治疗早期乳腺癌中芳香化酶抑制剂引起的肌肉骨骼症状的系统治疗。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD013167. doi: 10.1002/14651858.CD013167.pub2.
6
Interventions for fertility preservation in women with cancer undergoing chemotherapy.对接受化疗的癌症女性进行生育力保存的干预措施。
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗：一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
Mental Health First Aid as a tool for improving mental health and well-being.心理健康急救作为改善心理健康和福祉的工具。
Cochrane Database Syst Rev. 2023 Aug 22;8(8):CD013127. doi: 10.1002/14651858.CD013127.pub2.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
10
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
引用本文的文献
1
Curcumin as an antidote to atrazine on estrogen homeostasis and beyond: mechanistic insights from a targeted literature review.姜黄素作为阿特拉津对雌激素稳态及其他方面影响的解毒剂：基于针对性文献综述的机制见解
Front Endocrinol (Lausanne). 2025 Jul 23;16:1553465. doi: 10.3389/fendo.2025.1553465. eCollection 2025.
2
Estradiol (E2) concentration shapes the chromatin binding landscape of estrogen receptor alpha.雌二醇（E2）浓度塑造雌激素受体α的染色质结合图谱。
J Biol Chem. 2025 Apr 9:108499. doi: 10.1016/j.jbc.2025.108499.
3
Steroidogenic cytochrome P450 enzymes as drug target.作为药物靶点的类固醇生成细胞色素P450酶。
Toxicol Res. 2024 Apr 22;40(3):325-333. doi: 10.1007/s43188-024-00237-0. eCollection 2024 Jul.
4
Mammary Microvessels are Sensitive to Menstrual Cycle Sex Hormones.乳腺微血管对月经周期性激素敏感。
Adv Sci (Weinh). 2023 Dec;10(35):e2302561. doi: 10.1002/advs.202302561. Epub 2023 Oct 28.
5
Changes in the mammary gland during aging and its links with breast diseases.随着年龄增长，乳腺的变化及其与乳腺疾病的关系。
Acta Biochim Biophys Sin (Shanghai). 2023 May 15;55(6):1001-1019. doi: 10.3724/abbs.2023073.
6
Endocrine Disruptors in Food, Estrobolome and Breast Cancer.食品中的内分泌干扰物、雌激素代谢组与乳腺癌
J Clin Med. 2023 Apr 27;12(9):3158. doi: 10.3390/jcm12093158.
7
Phytoestrogens and Breast Cancer: Should French Recommendations Evolve?植物雌激素与乳腺癌：法国的建议是否应有所改变？
Cancers (Basel). 2022 Dec 14;14(24):6163. doi: 10.3390/cancers14246163.
8
Impact of intestinal dysbiosis on breast cancer metastasis and progression.肠道菌群失调对乳腺癌转移和进展的影响。
Front Oncol. 2022 Nov 7;12:1037831. doi: 10.3389/fonc.2022.1037831. eCollection 2022.
9
Vitamin D May Protect against Breast Cancer through the Regulation of Long Noncoding RNAs by VDR Signaling.维生素 D 可能通过 VDR 信号对长链非编码 RNA 的调节来预防乳腺癌。
Int J Mol Sci. 2022 Mar 16;23(6):3189. doi: 10.3390/ijms23063189.
10
Cul3 is required for normal development of the mammary gland.Cul3是乳腺正常发育所必需的。
Cell Tissue Res. 2021 Jul;385(1):49-63. doi: 10.1007/s00441-021-03456-1. Epub 2021 Apr 7.
本文引用的文献
1
Profiling endogenous serum estrogen and estrogen-glucuronides by liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法分析内源性血清雌激素及其葡萄糖醛酸结合物。
Anal Chem. 2009 Dec 15;81(24):10143-8. doi: 10.1021/ac9019126.
2
In situ estrogen production and its regulation in human breast carcinoma: from endocrinology to intracrinology.人乳腺癌中雌激素的原位生成及其调控：从内分泌学到细胞内分化学。
Pathol Int. 2009 Nov;59(11):777-89. doi: 10.1111/j.1440-1827.2009.02444.x.
3
Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status.在受体阳性乳腺癌中，组织雌二醇选择性升高，而肿瘤雌酮降低，且与受体状态无关。
J Steroid Biochem Mol Biol. 2009 Oct;117(1-3):31-41. doi: 10.1016/j.jsbmb.2009.06.005. Epub 2009 Jul 8.
4
Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women.性激素、生长因子与乳腺 X 光密度：英国绝经后白种人和非裔加勒比女性的横断面研究。
Breast Cancer Res. 2009;11(3):R38. doi: 10.1186/bcr2325. Epub 2009 Jun 22.
5
Biological significance of prolactin in gynecologic cancers.催乳素在妇科癌症中的生物学意义。
Cancer Res. 2009 Jun 15;69(12):5226-33. doi: 10.1158/0008-5472.CAN-08-4652. Epub 2009 Jun 2.
6
New developments in intracrinology of human breast cancer: estrogen sulfatase and sulfotransferase.人类乳腺癌内分泌学的新进展：雌激素硫酸酯酶和硫酸转移酶
Ann N Y Acad Sci. 2009 Feb;1155:76-9. doi: 10.1111/j.1749-6632.2008.03683.x.
7
A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability.一种同时测定15种尿雌激素和雌激素代谢物的液相色谱-质谱法：分析重现性和个体间变异性
Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3411-8. doi: 10.1158/1055-9965.EPI-08-0355.
8
Quantitation of steroid hormones in thin fresh frozen tissue sections.薄的新鲜冷冻组织切片中类固醇激素的定量分析。
Anal Chem. 2008 Nov 15;80(22):8845-52. doi: 10.1021/ac801402a. Epub 2008 Oct 21.
9
Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies.内源性激素水平与乳腺癌、子宫内膜癌和卵巢癌风险：前瞻性研究
Adv Exp Med Biol. 2008;630:148-65.
10
Multiplexed quantitation of endogenous estrogens and estrogen metabolites in human peritoneal fluid.人腹膜液中内源性雌激素和雌激素代谢物的多重定量分析。
Electrophoresis. 2008 Jun;29(12):2706-13. doi: 10.1002/elps.200700837.
Zotero 插件